Yakult Reduces Oncology Portfolio As It Looks Towards Microbiome

Multiple Products Transferred

 
• By Lisa Takagi
  
Yakult plans to transfer Elplat’s sales and distribution operations to Takata by April 2024.
Yakult plans to transfer cancer drug Elplat to Takata by April 2024 • Source: Shutterstock

More from Japan

More from Focus On Asia